Extended Viewer

Investing in the Fight Against Superbugs


16 mins listen August 30, 2024



Antimicrobial resistance is getting worse. Set to impact healthcare, agriculture and insurance, it’s a phenomenon worth paying attention to. On this episode, we take a look at whether there’s an investment case for fighting back against the superbugs. 

Loading Investing in the Fight Against Superbugs...

Featuring

Namita Nair

Vice President, MSCI Research

Related content